“Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s664. Accessed April 17, 2026. https://skin.dermsquared.com/skin/article/view/3886.